Objectively measured sleep and telomere length in a population-based cohort of children and midlife adults.


Journal

Sleep
ISSN: 1550-9109
Titre abrégé: Sleep
Pays: United States
ID NLM: 7809084

Informations de publication

Date de publication:
13 01 2020
Historique:
received: 23 04 2019
revised: 09 07 2019
pubmed: 17 11 2019
medline: 14 7 2020
entrez: 17 11 2019
Statut: ppublish

Résumé

Poor sleep patterns in older adults are associated with chromosomal telomere shortening, a marker of cellular senescence. However, studies have relied on self-reported sleep characteristics, with few data for younger individuals. We investigated whether sleep measured via actigraphy was cross-sectionally associated with telomere length in children and midlife adults. A population-based sample of 1874 11-12 year olds and midlife adults (mean age 44 years, SD 5.1) had biological and physical assessments at centers across Australia in 2015-2016. Sleep characteristics, including duration, onset, offset, day-to-day variability, and efficiency, were derived from actigraphy. Relative telomere length (T/S ratio) was measured by quantitative polymerase chain reaction on genomic DNA from peripheral blood. Multivariable regression models estimated associations, adjusting for prespecified confounders. Both sleep and telomere data were available for 728 children and 1070 adults. Mean (SD) T/S ratio was 1.09 (0.55) in children and 0.81 (0.38) in adults. T/S ratio was not predicted by sleep duration (β 0.04, 95% confidence interval [CI] -0.02 to 0.09, p = .16, children; β -0.004, 95% CI -0.03 to 0.02, p = .70, adults) or most other sleep metrics. The only exception was a weak association between later sleep timing (the midpoint of sleep onset and offset) and longer telomeres in adults (β 0.03, 95% CI 0.01 to 0.06, p = .01). Objective sleep characteristics show no convincing associations with telomere length in two largely healthy populations up to at least midlife. Sleep-telomere associations may be a late-life occurrence or may present only with a trigger such as presence of other morbidities.

Identifiants

pubmed: 31732749
pii: 5626508
doi: 10.1093/sleep/zsz200
pii:
doi:

Substances chimiques

Biomarkers 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Informations de copyright

© Sleep Research Society 2019. Published by Oxford University Press [on behalf of the Sleep Research Society]. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Auteurs

Minh Thien Nguyen (MT)

Prevention Innovation, Murdoch Children's Research Institute, Parkville, Australia.
Department of Paediatrics, University of Melbourne, Parkville, Australia.

Kate Lycett (K)

Prevention Innovation, Murdoch Children's Research Institute, Parkville, Australia.
Department of Paediatrics, University of Melbourne, Parkville, Australia.
School of Psychology, Deakin University, Parkville, Australia.

Timothy Olds (T)

School of Health Sciences, University of South Australia, Adelaide, Australia.

Lisa Matricciani (L)

School of Health Sciences, University of South Australia, Adelaide, Australia.

Regan Vryer (R)

Prevention Innovation, Murdoch Children's Research Institute, Parkville, Australia.
Department of Paediatrics, University of Melbourne, Parkville, Australia.

Sarath Ranganathan (S)

Prevention Innovation, Murdoch Children's Research Institute, Parkville, Australia.
Department of Paediatrics, University of Melbourne, Parkville, Australia.
Respiratory Medicine, Royal Children's Hospital, Parkville, Australia.

David Burgner (D)

Prevention Innovation, Murdoch Children's Research Institute, Parkville, Australia.
Department of Paediatrics, University of Melbourne, Parkville, Australia.
Infectious Diseases, Royal Children's Hospital, Parkville, Australia.
Department of Paediatrics, Monash University, Clayton, Australia.

Richard Saffery (R)

Prevention Innovation, Murdoch Children's Research Institute, Parkville, Australia.
Department of Paediatrics, University of Melbourne, Parkville, Australia.

Melissa Wake (M)

Prevention Innovation, Murdoch Children's Research Institute, Parkville, Australia.
Department of Paediatrics, University of Melbourne, Parkville, Australia.
Department of Paediatrics and Liggins Institute, University of Auckland, Auckland, New Zealand.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH